- Shopping Bag ( 0 items )
From The CriticsReviewer: Mony Fraer, MD, FACP, FASN(University of Iowa Hospitals and Clinics)
Description: Coming six years after the first edition, this is a necessary update of a book spanning the frontier of nephrology and oncology. The book has expanded to 360 pages and now it includes two new chapters on biologics and their effects (including toxicities of the EGFR and VEGF antagonists) and bone marrow transplant.
Purpose: It presents data and observations on cancer conditions of the kidney (as well as cancer as a complication of kidney transplantation) and how other cancers and treatments (including stem cell transplant) affect the kidney. The international authors keep the book's clinical focus: each chapter starts with a case study and poses relevant clinical questions, like when should we screen for kidney cancer and how can we identify patients at risk, and how to work up incidentally discovered cysts in the kidney.
Audience: The book is written for specialists and trainees in nephrology and oncology, but all practitioners in these fields would enjoy and benefit from reading it.
Features: The content is well organized, succinct yet inclusive. The book discusses acute renal failure, chronic kidney disease, end-stage renal disease, and renal transplantation. Other important topics in this area include: fluid and electrolyte disorders associated with cancer, radiation nephropathy and urinary tract obstruction in cancer patients. The references are up to date and the index is well organized.
Assessment: The discussion of malignancy-associated glomerulopathies is very comprehensive and I also liked the chapter on paraneoplastic glomerulopathies. The most exciting part of the book is the information on developments in cancer biology and the new treatments that are available — antibodies and agents with new targets. There are some histologic and radiologic images but the book would benefit from more and better images.s.